Klacid

Страна: Новая Зеландия

Язык: английский

Источник: Medsafe (Medicines Safety Authority)

Активный ингредиент:

Clarithromycin 50 mg/mL;  

Доступна с:

Viatris Limited

ИНН (Международная Имя):

Clarithromycin 50 mg/mL

дозировка:

250 mg/5mL

Фармацевтическая форма:

Granules for oral suspension

состав:

Active: Clarithromycin 50 mg/mL   Excipient: Carbomer Castor oil Citric acid monohydrate Hydrated silica Hypromellose phthalate Fruit mix flavour Maltodextrin Potassium sorbate Povidone Sucrose Titanium dioxide Xanthan gum

Штук в упаковке:

Bottle, plastic, 50 mL

класс:

Prescription

Тип рецепта:

Prescription

Производитель:

Zhejiang Guobang Pharmaceutical Co., Ltd

Терапевтические показания :

Klacid Suspension is indicated for treatment of infections caused by susceptible organisms. Such infections include: ? Upper respiratory infections (e.g. streptococcal pharyngitis). ? Lower respiratory infections (e.g. bronchitis, pneumonia). ? Acute otitis media. ? Skin and skin structure infections (e.g. impetigo, folliculitis, cellulitis, abscesses). ? Disseminated or localized mycobacterial infections due to Mycobacterium avium or Mycobacterium intracellulare. Localised infections due to Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasii.

Обзор продуктов:

Package - Contents - Shelf Life: Bottle, plastic, - 50 mL - 42 months from date of manufacture stored at or below 30°C 14 days reconstituted stored at or below 30°C - Bottle, plastic, - 100 mL - 42 months from date of manufacture stored at or below 30°C 14 days reconstituted stored at or below 30°C

Дата Авторизация:

1993-03-10

тонкая брошюра

Page 1 of 5
NEW ZEALAND CONSUMER MEDICINE INFORMATION
KLACID
®
, KLACID
®
IV
_CLARITHROMYCIN POWDER FOR ORAL LIQUID 250 MG/5 ML_
_FILM COATED TABLETS 250 MG AND 500 MG_
_POWDER FOR INJECTION 500 MG_
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully
before you start taking Klacid.
This leaflet answers some common
questions about this medicine.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have benefits and
risks. Your doctor has weighed the
risks of you taking Klacid against
the benefits they expect it will have
on you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, TALK TO YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE. You may need to read it
again.
WHAT KLACID IS USED
FOR
Klacid is used to treat certain
bacterial infections, including the
following:
•
respiratory tract infections
•
skin infections
•
ear infections
•
peptic ulcer
•
certain types of bacterial
infections
Klacid is also used to prevent a
specific bacterial infection
associated with HIV infection.
Klacid is an antibiotic that belongs
to the group of medicines called
macrolides. These medicines work
by killing or stopping the growth of
bacteria which cause infections.
Klacid will not work against
infections caused by viruses, such
as colds or flu.
Klacid is available only with a
doctor's prescription.
_KLACID TO TREAT PEPTIC _
_ULCER_
Peptic ulcers are associated with an
infection in the intestine and
stomach caused by a bacteria
called Helicobacter pylori (H. pylori).
Nearly all patients with peptic ulcers
are infected with this bacterium.
The H. pylori infection can be
treated with a combination of Klacid
(clarithromycin) and other
appropriate antibiotic and stomach
acid control treatments. Your
doctor will determine the best
combination for you.
If your symptoms return, consult
your doctor. It is possible that Klacid
may no longer be effective in killing
the H. pylori infection and a different
antibiotic may be needed.

Характеристики продукта

Page 1 of 33
NEW ZEALAND DATA SHEET
KLACID
®
, KLACID
® IV
1. PRODUCT NAME
Klacid, 250 mg and 500 mg, film coated tablet.
Klacid, 125 mg/5 mL and 250 mg/5 mL, granules for oral suspension.
Klacid IV, 500 mg, powder for injection.
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Klacid 250 mg: Each film coated tablet contains 250 mg of
clarithromycin.
Klacid 500 mg: Each film coated tablet contains 500 mg of
clarithromycin.
Klacid 125 mg/5 ml: Each 5 ml of the granules for suspension contains
125 mg of clarithromycin.
Klacid 250 mg/5 ml: Each 5 ml of the granules for suspension contains
250 mg of clarithromycin.
Klacid IV: Each vial contains 739.5 mg clarithromycin lactobionate,
corresponding to 500 mg of
clarithromycin.
For the full list of excipients, see section 6.1.
Klacid Suspension: Contains sugars and sorbates.
Klacid Tablet: Contains sorbates
3. PHARMACEUTICAL FORM
Klacid 250 mg – yellow, ovaloid, film coated tablets.
Klacid 500 mg – pale yellow, ovaloid, film coated tablets.
Klacid 125 mg/5 ml: white to off-white granules.
Klacid 250 mg/5 ml: white to off-white granules.
Klacid IV: white to off-white caked, lyophilized powder.
4. CLINICAL PARTICULARS
_4.1 _
_THERAPEUTIC INDICATIONS_
Klacid
I.V.
is
indicated
whenever
parenteral
therapy
is
required
for
treatment
of
sensitive
microorganisms in the following conditions:
Page 2 of 33

Upper respiratory tract infections.

Lower respiratory tract infections (see section 4.4 and 5.1 regarding
Sensitivity testing).

Skin and soft tissue infections (see section 4.4 and 5.1 regarding
Sensitivity testing).
Klacid Suspension is indicated for treatment of infections caused by
susceptible organisms. Such
infections include:

Upper respiratory infections (e.g. streptococcal pharyngitis).

Lower respiratory infections (e.g. bronchitis, pneumonia) (see section
4.4 and 5.1 regarding
Sensitivity testing).

Acute otitis media.

Skin and skin structure infections (e.g. impetigo, folliculitis,
cellulitis, abscesses) (see section
4.4 and 5.1 regarding Sensi